| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/26/2002 | US20020137061 Novel adenosine deaminase homolog |
| 09/26/2002 | US20020137058 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 09/26/2002 | US20020137056 Calibration of signals |
| 09/26/2002 | US20020137053 Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening |
| 09/26/2002 | US20020137049 Pablo, a polypeptide that interacts with Bcl-xL, and uses related thereto |
| 09/26/2002 | US20020137046 Detection uisng mass spectrometry |
| 09/26/2002 | US20020137045 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids |
| 09/26/2002 | US20020137043 Method for reducing complexity of nucleic acid samples |
| 09/26/2002 | US20020137041 Using fish models; cancer therapy |
| 09/26/2002 | US20020137038 Intestinal proteins |
| 09/26/2002 | US20020137035 Hybrid analyzing; tuberculosis diagnosis |
| 09/26/2002 | US20020137029 Identification of numerical changes in cell dna |
| 09/26/2002 | US20020137028 Use of neuronal apoptosis inhibitor protein (naip) |
| 09/26/2002 | US20020137026 Detection and characterization of microorganisms |
| 09/26/2002 | US20020137023 Methods and compositions for targeting compounds to muscle |
| 09/26/2002 | US20020137022 Genetic engineering; determination binding |
| 09/26/2002 | US20020137021 Nucleic acid primers and probes for detecting oncogenic human papillomaviruses |
| 09/26/2002 | US20020137019 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases |
| 09/26/2002 | US20020136754 Recombinant bacterial phytases and uses thereof |
| 09/26/2002 | US20020136736 Or prophylactically or therapeutically effective fragment thereof in admixture with a pharmaceutically acceptable carrier |
| 09/26/2002 | US20020136730 From coagulase-negative bacteria produced in substantially pure form; use of purified adhesin product as vaccine for production of antibodies effective against binding of homologous bacterial cells to polymeric materials |
| 09/26/2002 | US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 09/26/2002 | US20020136720 Methods of using IMXP-888 and IMXP-888 antagonists |
| 09/26/2002 | US20020136713 Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV |
| 09/26/2002 | US20020136710 Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV |
| 09/26/2002 | US20020136708 System for production of helper dependent adenovirus vectors based on use of endonucleases |
| 09/26/2002 | US20020136707 Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof |
| 09/26/2002 | DE10113876A1 Quantitative diagnosis of genetically related hypertension, by correlating blood pressure with overexpression or modification of human sgk family proteins |
| 09/26/2002 | DE10112992A1 New isolated polynucleotide from coryneform bacteria, useful for increasing production of amino acids, comprises extended genes for 1- or 6- phosphofructokinase |
| 09/26/2002 | CA2852293A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
| 09/26/2002 | CA2469846A1 New interferon beta-like molecules |
| 09/26/2002 | CA2460779A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells |
| 09/26/2002 | CA2442036A1 Stress-responsive activator of p300 (strap) protein |
| 09/26/2002 | CA2441902A1 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | CA2441820A1 Evolving new molecular function |
| 09/26/2002 | CA2441813A1 Disease associated polymorphism in the ctla-4 locus |
| 09/26/2002 | CA2441740A1 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 09/26/2002 | CA2441564A1 Production of pancreatic islet cells and delivery of insulin |
| 09/26/2002 | CA2441510A1 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | CA2441503A1 Method for cleaving human growth hormone gh |
| 09/26/2002 | CA2441388A1 Modified insulin with reduced immunogenicity |
| 09/26/2002 | CA2441291A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/26/2002 | CA2441275A1 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening |
| 09/26/2002 | CA2441265A1 Sugar and lipid metabolism regulators in plants |
| 09/26/2002 | CA2441233A1 Cell cycle nucleic acids, polypeptides and uses thereof |
| 09/26/2002 | CA2441095A1 Modified interferon beta with reduced immunogenicity |
| 09/26/2002 | CA2441057A1 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 09/26/2002 | CA2441042A1 Monoclonal antibody therapy for pancreas cancer |
| 09/26/2002 | CA2441021A1 Method for alteration detection |
| 09/26/2002 | CA2440966A1 Characterization of the i-spomi endonuclease from fission yeast |
| 09/26/2002 | CA2440960A1 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 09/26/2002 | CA2440956A1 Oligonucleotides for regulating the gene coding for tnf.alpha. and/or genes controlled thereby and use thereof |
| 09/26/2002 | CA2440859A1 Transgenic animal model of ige-mediated allergic responses |
| 09/26/2002 | CA2440749A1 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 09/26/2002 | CA2440747A1 Novel nucleic acids and polypeptides |
| 09/26/2002 | CA2440623A1 Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related diseasestates |
| 09/26/2002 | CA2440584A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/26/2002 | CA2440028A1 Rearranged squamous cell carcinoma antigen genes ii |
| 09/26/2002 | CA2439916A1 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/26/2002 | CA2439757A1 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells |
| 09/26/2002 | CA2439315A1 Compositions useful in gene therapy |
| 09/26/2002 | CA2438483A1 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | CA2438315A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
| 09/26/2002 | CA2438279A1 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 09/26/2002 | CA2435857A1 Methods for embryo recipient management |
| 09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
| 09/26/2002 | CA2435000A1 Oligomeric complexes of chimeric proteins with enhanced immunogenic potential |
| 09/26/2002 | CA2425902A1 Urocortin-iii and uses thereof |
| 09/25/2002 | EP1243661A1 Method for reverse transcription |
| 09/25/2002 | EP1243659A1 Method for detecting target nucleotide sequences |
| 09/25/2002 | EP1243658A1 Method of measuring deacetylase activity and method of screening inhibitor or promoter of these enzymes |
| 09/25/2002 | EP1243656A2 Novel baculovirus transfer vectors and recombinant baculoviruses for exogenous gene expression |
| 09/25/2002 | EP1243655A1 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 09/25/2002 | EP1243654A1 Precursor polypeptides of phytosulfokine derived from Arabidopsis thaliana and cDNAs encoding said polypeptides |
| 09/25/2002 | EP1243653A2 E25a protein, methods for producing and use thereof |
| 09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
| 09/25/2002 | EP1243650A2 Process for constructing a cdna library, and a polypeptide and dna coding for the same |
| 09/25/2002 | EP1243649A1 Method for the isolation of DNA |
| 09/25/2002 | EP1243646A2 Transgenic Drosophila with human APC gene for pharmacological screenings |
| 09/25/2002 | EP1243645A1 Penicillin production using transgenic merodiploid strains |
| 09/25/2002 | EP1243597A2 Receptors for human interleukin-12 |
| 09/25/2002 | EP1243596A2 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase and methods for identification of inhibitors thereof |
| 09/25/2002 | EP1243595A1 Bh4-fused polypeptides |
| 09/25/2002 | EP1243290A2 Modulation of gene expression by combination therapy |
| 09/25/2002 | EP1243289A2 Modulation of gene expression by combination therapy |
| 09/25/2002 | EP1242902A1 Employing synthetic genes in genetic algorithms, information encoding and non-replicative encryption |
| 09/25/2002 | EP1242823A2 Selecting library members capable of binding to epitopes |
| 09/25/2002 | EP1242821A1 Direct screening method |
| 09/25/2002 | EP1242819A2 Apparatus for performing biological reactions |
| 09/25/2002 | EP1242816A2 Chromatography material and a method using same |
| 09/25/2002 | EP1242814A2 Flow cell for synthesis of arrays of dna probes and the like |
| 09/25/2002 | EP1242633A1 Nucleic acid amplification and detection of mycobacterium species |
| 09/25/2002 | EP1242631A1 Multispecies food testing and characterization |
| 09/25/2002 | EP1242629A2 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
| 09/25/2002 | EP1242626A1 Detection of nucleic acids |
| 09/25/2002 | EP1242625A1 Probes and primers for the detection of polyphosphate accumulating organisms in wastewater |
| 09/25/2002 | EP1242624A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 09/25/2002 | EP1242622A2 Monitoring oligonucleotide binding processes using chemiluminescence quenching |
| 09/25/2002 | EP1242620A2 Fluorescent intensity assay for duplex and triplex nucleic acid hybridization in solution utilizing fluorescent intercalators |